NDC 80425-0199-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0199
- Requested NDC
- 80425-0199-01
- Package NDCs from labels
- 80425-0199-2, 80425-0199-3, 80425-0199-1, 80425-0199-4, 80425-0199-01
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-12-31
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-12-31 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0199-1 | Gabapentin | 30 in 1 BOTTLE | CAPSULE | 30 | 5 | |
| 80425-0199-2 | Gabapentin | 60 in 1 BOTTLE | CAPSULE | 60 | 5 | |
| 80425-0199-3 | Gabapentin | 90 in 1 BOTTLE | CAPSULE | 90 | 5 | |
| 80425-0199-4 | Gabapentin | 120 in 1 BOTTLE | CAPSULE | 120 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0199 | GABAPENTIN CAPSULE [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 5 | Current NDC, Legacy NDC, 4 package rows | 20250101_ec1c621b-db2a-1567-e053-2995a90a8695.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0199-1 | EA - Each | 80425-0199 | d68dc437-0849-41c2-b17b-257d12f6b61c | 1 | 2023-06-06 |
| 80425-0199-2 | EA - Each | 80425-0199 | 72852c7a-f605-4712-bd72-41cd7fab8078 | 1 | 2023-06-06 |
| 80425-0199-3 | EA - Each | 80425-0199 | d088f4ae-c84a-47de-954a-d5659921b2bf | 1 | 2023-06-06 |
| 80425-0199-4 | EA - Each | 80425-0199 | 23d7cfee-4b7b-41a1-a066-247e8cdd763e | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | ba4d863d-be38-8cf5-e053-2995a90a69fb | 2026-06-26 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | c85ae572-9893-629e-e053-2995a90a23fc | 2026-06-26 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Zhejiang Yongtai Pharmaceutical Co., Ltd | f1eda6cc-d9b2-4df4-a09b-20eebded760f | 2026-06-25 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Northwind Health Company, LLC | 552912b2-be59-0333-e063-6394a90a85c0 | 2026-06-25 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Northwind Health Company, LLC | 55292235-bf8f-46d0-e063-6294a90a91a5 | 2026-06-25 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Unit Dose Solutions, Inc. | 54ecc64b-f019-9fcb-e063-6294a90a00af | 2026-06-23 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Unit Dose Solutions, Inc. | 54edd6f3-06c7-a0c7-e063-6394a90a8b4f | 2026-06-23 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Teva Pharmaceuticals, Inc. | c7f21eaa-68ee-420c-9c98-e997cc73a297 | 2026-06-23 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Northwind Health Company, LLC | 1b44a3ab-4d06-205f-e063-6294a90af368 | 2026-06-22 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Unit Dose Solutions, Inc. | 54dc347e-cba0-ea73-e063-6294a90ab436 | 2026-06-22 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | St. Mary's Medical Park Pharmacy | 235a6954-318a-9e3a-e063-6394a90a0e21 | 2026-06-19 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Bryant Ranch Prepack | c9f0cceb-b24e-4526-b873-fedd877d6bc6 | 2026-06-18 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | Granules Pharmaceuticals Inc | c681c804-c6f3-d63b-e053-2995a90a6b8f | 2026-06-17 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Asclemed USA, Inc. | 9a829dc3-b2d8-4d19-a579-0597217cec9b | 2026-06-17 | Warnings, Adverse reactions | 310430 310432 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | d8604417-9d43-4d27-a7ce-d4120ff201f4 | 2026-06-11 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | St. Mary's Medical Park Pharmacy | b7a29b99-ce23-950e-e053-2995a90a1934 | 2026-06-09 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 4c49d34d-bb47-406b-8f2d-b4834b2ee9d0 | 2026-06-08 | Warnings, Adverse reactions | 310430 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Coupler LLC | 5385e27c-f2fa-32d5-e063-6294a90a0a8c | 2026-06-05 | Warnings, Adverse reactions | 310431 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Ascend Laboratories, LLC | 4d445d1d-02d1-4a59-b3b2-9ba5cd924c9a | 2026-06-04 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | St. Mary's Medical Park Pharmacy | 07f07d15-ee91-8c2a-e063-6394a90a4624 | 2026-06-03 | Warnings, Adverse reactions | 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.